BioSpace News Archive

Drug Development

NexImmune Presents Initial Positive Data from the NEXI-001 Phase 1 Trial for Relapsed/Refractory Post Allo-HSCT AML at the American Society of Clinical Oncology 2023 Annual Meeting

NexImmune, Inc. (Nasdaq: NEXI) today announced results from its Phase 1/2 clinical trial of NEXI-001 in patients with relapsed/refractory acute myeloid leukemia (AML) post-allogeneic hemopoietic stem cell transplant (allo-HSCT).

June 5, 2023
·
9 min read
Genetown

Candel Therapeutics to Participate in the 2023 Jefferies Healthcare Conference

Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL) today announced that Paul Peter Tak, MD, PhD, FMedSci, President and Chief Executive Officer, will give a corporate presentation at the upcoming Jefferies Healthcare Conference, taking place June 7 – 9, 2023, in New York City.

June 5, 2023
·
3 min read
Pharm Country

Timber Pharmaceuticals Announces FDA Grant of CARC Waiver for TMB-001

Timber Pharmaceuticals, Inc. (“Timber” or the “Company”) (NYSE American: TMBR) today announced the U.S. Food and Drug Administration (FDA) has granted a dermal carcinogenicity (CARC) waiver for TMB-001, a topical isotretinoin formulated using the Company’s patented IPEG™ delivery system.

June 5, 2023
·
4 min read
Biotech Beach

Shimadzu Medical Systems USA receives an IMV ServiceTrak Award in the General X-ray category

Shimadzu Medical Systems USA, a subsidiary of Shimadzu Corporation, receives an IMV ServiceTrak Award in the General X-ray Systems category.

June 5, 2023
·
2 min read
Business

RoslinCT and Lykan Bioscience Announce Integration to Establish Global Advanced Cell and Gene Therapy CDMO Service Offerings

RoslinCT and Lykan Bioscience, two leading Contract Development and Manufacturing Organizations (CDMOs) in the Cell and Gene Therapy industry, announce their integration, creating a unified business that will operate under the RoslinCT brand.

June 5, 2023
·
3 min read
BioCapital

Novavax Announces Agreement with Bill & Melinda Gates Medical Research Institute to Include Matrix-M™ Adjuvant as Potential Component in Vaccine Research

Novavax, Inc., a global company advancing protein-based vaccines with its novel Matrix-M™ adjuvant, has signed a three-year agreement with the Bill & Melinda Gates Medical Research Institute to provide its adjuvant for use in preclinical vaccine research.

June 5, 2023
·
4 min read
Genetown

Thermo Fisher Scientific Introduces Groundbreaking Mass Spectrometer to Revolutionize Biological Discovery

Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today unveiled the Thermo Scientific™ Orbitrap™ Astral™ mass spectrometer, one of the most significant advancements in mass spectrometry in 15 years.

June 5, 2023
·
4 min read
Lone Star Bio

Thermo Fisher Scientific Showcases Solutions for Accelerating Biological Discovery

Thermo Fisher Scientific is showcasing new mass spectrometry and chromatography instruments, software and workflows that enable customers to unlock deeper analytical insights, improve productivity and accelerate biological discovery.

June 5, 2023
·
5 min read
Business

Variant Bio Takes Critical Step Toward the Discovery of Novel Medicines With the Appointment of Two Industry Leaders

Variant Bio, a genomics-driven drug discovery company, is pleased to welcome two stars of biopharma innovation to its leadership: David Moller, MD, as Chief Scientific Officer, and Steve Bryant, PhD, as Chief Business Officer.

June 5, 2023
·
5 min read
BioMidwest

GE HealthCare Introduces Sonic DL: A Groundbreaking, FDA-Cleared AI Deep Learning Technology for Faster MRI

GE HealthCare (Nasdaq: GEHC) today announced the FDA clearance and launch of Sonic DL – a state-of-the-art deep learning-based technology designed to dramatically accelerate image acquisition in magnetic resonance imaging (MRI).

June 5, 2023
·
4 min read